Please login to the form below

I have forgotten my password

FujiFilm

This page shows the latest FujiFilm news and features for those working in and with pharma, biotech and healthcare.

NHS says Humira biosimilar deal will save £300m

s Cyltezo and Mylan’s Hulio, the latter sublicensed from Japan’s Fujifilm Kyowa Kirin.

Latest news

First Humira biosimilars reach EU market

Copycat versions of the TNF inhibitor from Amgen, Samsung Bioepis/Biogen, Mylan/Fujifilm Kyowa Kirin, and Novartis’ Sandoz unit are starting to become available in their first EU markets now that ... Imraldi. There is no word yet on the roll-out
Fujifilm expands biopharma development and manufacturing business

Company invests 3.2bn yen in US and UK sites. Fujifilm Corporation is investing 3.2bn yen ($28m) to expand the biopharmaceutical manufacturing and development operations of its contract development and ... More specifically, the new investment will
Novartis to buy French radiopharma specialist AAA for $3.9bn

The first patient was recently treated with the drug in Japan, where it is partnered with Fujifilm RI Pharma.
Shire gives up on Momenta-partnered Humira biosimilar

Samsung Bioepis is in pole position in Europe having filed for approval of its SB5 biosimilar in July, while Sandoz, Merck KGaA and FujiFilm/Kyowa Hakko Kirin have candidates in phase
Developing therapeutic cancer vaccines

GreenPeptide and its licensee FUJIFILM are developing a vaccine for HLA-A2-positive advanced cancer, ITK 1, which consists of twelve different CAAs.

More from news
Approximately 2 fully matching, plus 4 partially matching documents found.

Latest Intelligence

Deal Watch March 2016

The sale of the diagnostic imaging business was believed to be hotly contested by Fujifilm and Konica Minolta, with Canon the successful bidder.
Pharma deals in July 2015

Still in Japan, a week later AZ agreed a joint venture with Fujifilm Kyowa Kirin Biologics for the development and commercialisation of a biosimilar version of bevacizumab (Avastin) in phase I ... Fujifilm Kyowa KirinBiologics will transfer the product
Pharma deals in March 2015

The high level of interest in cell therapies generally may have been one reason why Fujifilm acquired Cellular Dynamics for $307m at an eye watering share price premium of 108%. ... Fujifilm expects to achieve significant synergies. Checkpoint inhibitors

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

BIA elects six new board members

The remaining new appointments are Stephen Taylor of Fujifilm Diosynth Biotechnologies; Donna Hackett, director of life sciences consultancy firm KDH BioManagement; and Tim Watts, chief financial officer of Oxford BioMedica.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Technical Manager – Developer and Commercial Excellence, Healthc...: Excellent package

Senior Account Manager, Rare Diseases – Medical Communications, ...: Excellent package

Associate Director: £75, 000-90, 000

Senior Medical Writer: Salary TBC

Senior Account Manager: Competitive Salary Offered

Client Services Director – Medical Education Agency – North West...: Salary TBC

Account Director, Healthcare Marketing Agency: Salary TBC

Home-based Senior Project Manager – Independent Med Ed: Salary TBC

Account Manager / Account Director: Competative

Account Director – Healthcare Marketing – Berks: Salary TBC

Account Director, Medical Education: Salary TBC

Account Director – Health Policy – Global Agency: Salary TBC

Editorial Assistant Medical Education Agency: £25, 000 - £26, 000

Account Director: Competitive Salary Offered

Medical Writer: Salary TBC

Global Business Development Director – Health Education: excellent commission

Account Manager / Senior Account Manager: 35, 000-40, 000

Business Director: Competitive Salary Offered

Senior Account Director development role to Business Director, H...: Excellent package

PRINCIPAL MEDICAL WRITER > ETL - LONDON / NEW YORK/ HOME - ME...: Salary TBC

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Engagement Expert, Healthcare Brand Communications, London: Excellent package

Subscribe to our email news alerts

PMHub

Add my company

Bedrock Healthcare Communications

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

China’s clinical trial shake-up: As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?: Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement: Pharma has agreed to capped growth again - in exchange for uptake promises...